Zobrazeno 1 - 10
of 148
pro vyhledávání: '"L Nieuwenhuizen"'
Autor:
Marjon H Cnossen, Frank W G Leebeek, Ron A A Mathôt, M Coppens, MJHA Kruip, S Polinder, K Fischer, R Liesner, K Fijnvandraat, Laura H Bukkems, PW Collins, P Chowdary, K Meijer, A Janssen, MH Cnossen, Jessica M Heijdra, Wala Al Arashi, Nico C B de Jager, Michael E Cloesmeijer, Christian M Zwaan, FWG Leebeek, RAA Mathôt, RYJ Tamminga, BAP Laros-van Gorkom, P Brons, SEM Schols, FJM van der Meer, HCJ Eikenboom, REG Schutgens, F Heubel-Moenen, L Nieuwenhuizen, P Ypma, MHE Driessens, CM Zwaan, I van Vliet, D Keeling, J Lock, HCAM Hazendonk, I van Moort, T Preijers, JM Heijdra, NCB de Jager, MCHJ Goedhart, LH Bukkems, W Al Arashi, ME Cloesmeijer
Publikováno v:
BMJ Open, Vol 12, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/1965d1889ddf4cbeb8a1d66664e6a252
Autor:
Linda C. Smit, Niek J. De Wit, Meggie L. Nieuwenhuizen, Marieke J. Schuurmans, Nienke Bleijenberg
Publikováno v:
BMC Geriatrics, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background The effectiveness of health care interventions is co-determined by contextual factors. Unknown is the extent of this impact on patient outcomes. Therefore, the aim of this study is to explore which characteristics of general pract
Externí odkaz:
https://doaj.org/article/b95fdfc22e6b434ea79d6324a6d84945
Autor:
F. Atiq, J.L. Saes, M.C. Punt, K.P.M. van Galen, R.E.G. Schutgens, K. Meijer, M.H. Cnossen, B.A.P. Laros-Van Gorkom, M. Peters, L. Nieuwenhuizen, M.J.H.A. Kruip, J. de Meris, J.G. van der Bom, F.J.M. van der Meer, K. Fijnvandraat, I.C. Kruis, W.L. van Heerde, H.C.J. Eikenboom, Frank W.G. Leebeek, S.E.M. Schols
Publikováno v:
EClinicalMedicine, Vol 32, Iss , Pp 100726- (2021)
Background: In recent years, more awareness is raised about sex-specific dilemmas in inherited bleeding disorders. However, no large studies have been performed to assess differences in diagnosis, bleeding phenotype and management of men and women wi
Externí odkaz:
https://doaj.org/article/56151185cb9446578fedf195290b6507
Autor:
Dominique P.M.S.M. Maas, Joline L. Saes, Nicole M.A. Blijlevens, Marjon H. Cnossen, Paul L. den Exter, Olivier W.H. van der Heijden, Ilmar C. Kruis, Karina Meijer, Marjolein Peters, Roger E.G. Schutgens, Waander L. van Heerde, Laurens Nieuwenhuizen, Saskia E.M. Schols, D.P.M.S.M. Maas, J.L. Saes, K. Meijer, M.H. Cnossen, R.E.G. Schutgens, M. Peters, L. Nieuwenhuizen, P.L. den Exter, I.C. Kruis, W.L. van Heerde, S.E.M. Schols
Publikováno v:
Journal of Thrombosis and Haemostasis, 21, 499-512
Journal of thrombosis and haemostasis : JTH, 21(3), 499-512. Wiley-Blackwell Publishing Ltd
Journal of Thrombosis and Haemostasis, 21, 3, pp. 499-512
Journal of thrombosis and haemostasis : JTH, 21(3), 499-512. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, 21(3), 499-512. Wiley
Journal of thrombosis and haemostasis : JTH, 21(3), 499-512. Wiley-Blackwell Publishing Ltd
Journal of Thrombosis and Haemostasis, 21, 3, pp. 499-512
Journal of thrombosis and haemostasis : JTH, 21(3), 499-512. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, 21(3), 499-512. Wiley
Item does not contain fulltext BACKGROUND: Women with rare bleeding disorders (RBDs), including coagulation factor deficiencies and fibrinolytic disorders, may have a higher risk of postpartum hemorrhage (PPH). Information on this patient category is
Autor:
Tine M.H.J. Goedhart, Laura H. Bukkems, Michiel Coppens, Karin J. Fijnvandraat, Saskia E.M. Schols, Roger E.G. Schutgens, Jeroen Eikenboom, Floor C.J.I. Heubel-Moenen, Paula F. Ypma, L. Nieuwenhuizen, K. Meijer, Frank W. G. Leebeek, Ron A.A. Mathôt, Marjon H. Cnossen
Publikováno v:
TH open : companion journal to thrombosis and haemostasis, 6(1), e60-e69
Th Open, 6, e60-e69
TH Open (2022)
Th Open, 6, 1, pp. e60-e69
Th Open, 6, e60-e69
TH Open (2022)
Th Open, 6, 1, pp. e60-e69
Contains fulltext : 248777.pdf (Publisher’s version ) (Open Access) In resource-rich countries, almost all severe hemophilia patients receive prophylactic replacement therapy with factor concentrates to prevent spontaneous bleeding in joints and mu
Autor:
Jessica M. Heijdra, Ferdows Atiq, Wala Al Arashi, Quincy Kieboom, Esmee Wuijster, Karina Meijer, Marieke J.H.A. Kruip, Frank W.G. Leebeek, Marjon H. Cnossen, K. Fijnvandraat, R.A.A. Mathôt, S. Polinder, M. Coppens, R.Y.J. Tamminga, K. Meijer, B.A.P. Laros‐van Gorkom, P. Brons, S.E.M. Schols, F.J.M. van der Meer, H.C.J. Eikenboom, R.E.G. Schutgens, K. Fischer, F. Heubel‐Moenen, L. Nieuwenhuizen, P. Ypma, M.H.E. Driessens, C.M. Zwaan, I. van Vliet, P.W. Collins, R. Liesner, P. Chowdary, D. Keeling, J. Lock, H.C.A.M. Hazendonk, I. van Moort, T. Preijers, N.C.B. de Jager, M.C.H.J. Goedhart, L.H. Bukkems, M.E. Cloesmeijer, A. Janssen
Publikováno v:
Research and practice in thrombosis and haemostasis, 6(6):e12784. Wiley-Blackwell Publishing Ltd
Research and Practice in Thrombosis and Haemostasis, 6(6):e12784. Wiley-Blackwell Publishing Ltd
Research and practice in thrombosis and haemostasis, 6(6):e12784. Wiley
Research and Practice in Thrombosis and Haemostasis, 6(6):e12784. Wiley-Blackwell Publishing Ltd
Research and practice in thrombosis and haemostasis, 6(6):e12784. Wiley
Background: Individuals with von Willebrand disease (VWD) require desmopressin testing because of interindividual response differences. However, testing is burdensome, while not all patients may need extensive testing.Objectives: To provide von Wille
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e0a565361a6f821a227ac15b88756ac
https://pure.amc.nl/en/publications/desmopressin-testing-in-von-willebrand-disease(e39b8cf5-28d9-4e8d-aaea-05ff14efa6d6).html
https://pure.amc.nl/en/publications/desmopressin-testing-in-von-willebrand-disease(e39b8cf5-28d9-4e8d-aaea-05ff14efa6d6).html
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marjon H Cnossen, Frank W G Leebeek, Ron A A Mathôt, M Coppens, MJHA Kruip, S Polinder, K Fischer, R Liesner, K Fijnvandraat, Laura H Bukkems, PW Collins, P Chowdary, K Meijer, A Janssen, MH Cnossen, Jessica M Heijdra, Wala Al Arashi, Nico C B de Jager, Michael E Cloesmeijer, Christian M Zwaan, FWG Leebeek, RAA Mathôt, RYJ Tamminga, BAP Laros-van Gorkom, P Brons, SEM Schols, FJM van der Meer, HCJ Eikenboom, REG Schutgens, F Heubel-Moenen, L Nieuwenhuizen, P Ypma, MHE Driessens, CM Zwaan, I van Vliet, D Keeling, J Lock, HCAM Hazendonk, I van Moort, T Preijers, JM Heijdra, NCB de Jager, MCHJ Goedhart, LH Bukkems, W Al Arashi, ME Cloesmeijer
Publikováno v:
BMJ Open, Vol 12, Iss 2 (2022)
BMJ open, 12(2):e049493. BMJ Publishing Group
BMJ Open, 12(2):e049493. BMJ Publishing Group
BMJ open, 12(2):e049493. BMJ Publishing Group
BMJ Open, 12(2):e049493. BMJ Publishing Group
IntroductionVon Willebrand disease (VWD) is a bleeding disorder, caused by a deficiency or defect of von Willebrand factor (VWF). In case of medical procedures or bleeding, patients are treated with desmopressin and/or VWF-containing concentrates to
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.